Evogene Shareholders Approve Board Slate, Ending Activist Proxy Fight
EVGN sits 54% above its 52-week low of $0.37.
Summary
Evogene shareholders approved the incumbent board slate at the September 4 annual meeting, ending the activist proxy fight that had escalated since July.
Key Events · Corporate Governance and Compliance · EVGN
-
Incumbent Board Slate Approved
Shareholders approved Proposals Nos. 1(a) and 2-4, confirming the seven-member board including CEO Ofer Haviv and director Leon Recanati.
-
Activist Proxy Fight Resolved
The activist group led by L.I.A. Pure Capital, which held a 19.35% stake and demanded a board overhaul, did not gain control.
-
Board Composition Confirmed
The board now consists of Nir Nimrodi, Adrian Percy, Leon Y. Recanati, Dan Falk, Yael Margolin, Yoshinori Oikawa, and Ofer Haviv.
-
Prior-Disclosure Context
The proxy statement was filed July 31, 2026, and director Recanati had pledged to vote for the incumbent board in the September 4 meeting.
Analysis · EVGN · Industrial Applications And Services
The annual general meeting vote resolves the high-stakes proxy battle with activist shareholders that has dominated Evogene's recent filings. Shareholders approved the incumbent board slate, including CEO Ofer Haviv and director Leon Recanati, who had pledged to vote for the incumbent board. The activist group, which had accumulated a 19.35% stake and demanded a board overhaul, did not prevail. This outcome removes a major governance overhang and provides clarity on the company's leadership going forward.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.6% of the 1759 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVGN was trading at $0.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8.6M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.